|

Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients

RECRUITINGPhase 3Sponsored by Beijing Tiantan Hospital
Actively Recruiting
PhasePhase 3
SponsorBeijing Tiantan Hospital
Started2025-10-09
Est. completion2027-12-30
Eligibility
Age18 Years – 70 Years
Healthy vol.Accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of steroids treatment compared with placebo in preserving facial nerve function after craniotomy in patients with vestibular schwannoma who have not received preoperative treatment and have good intraoperative facial nerve function.

Eligibility

Age: 18 Years – 70 YearsHealthy volunteers accepted
Inclusion Criteria:

1. Age between 18 and 70 years
2. Diagnosed with untreated unilateral vestibular schwannoma
3. No facial palsy before surgery (House-Brackmann grade I)
4. Intraoperative neurophysiological monitoring confirms good facial nerve function preservation, defined as: a)Post-tumor resection, evoked compound muscle action potential amplitude \>420 μV under 0.05 mA stimulation;and b)The amplitude is \>60% of baseline value measured before dural opening
5. Signed informed consent

Exclusion Criteria:

1. Contraindications for craniotomy
2. Patients requiring corticosteroids during the perioperative period, or with known corticosteroid contraindications
3. Patients or first-degree relatives with a confirmed diagnosis of neurofibromatosis type 2 (NF2)
4. Karnofsky Performance Status (KPS) score \<90 before disease onset
5. Pregnant or planning to become pregnant during the study period
6. Participation in other interventional clinical trials
7. Judged unsuitable by the investigators

Conditions3

CancerFacial Nerve ParalysisVestibular Schwannoma

Interventions1

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.